Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202
- Citation:
- Leukemia vol 35 (10) 2854-61
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 11
- Parents:
- 3251
- Children:
- None
- Pharmas:
- Pharmacyclics
- Grants:
- U10CA180821, U10CA180882, U24CA196171; UG1CA232760, UG1CA233180, UG1CA233253, UG1CA233327, UG1CA233331, R35CA198183, R01CA192928, U10CA180863 (CCTG)
- Corr. Author:
- Authors:
- Amy S. Ruppert Allison M. Booth Wei Ding Nancy L. Bartlett Danielle M. Brander Steven Coutre Jennifer R. Brown Sreenivasa Nattam Richard A. Larson Harry Erba Mark Litzow Carolyn Owen Charles S. Kuzma Jeremy S. Abramson Richard F. Little Scott E. Smith Richard M. Stone John C. Byrd Sumithra J. Mandrekar Jennifer A. Woyach
- Networks:
- IL017, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OH007, OH070, SCOR
- Study
- Alliance-A041202
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: